Advertisement

Advertisement

#47: An Expanded Role for Pharmacists

Welcome to 3P: Pills, Pearls, and Patients where we will discuss current events in medicine, stories from real patient-physician encounters, and gain insight into what it's like being a physician in today's society.

Please note that while the first episode is available to listen to without registration, accessing additional episodes will require you to subscribe and log in.

  Back to Pills, Pearls & Patients (3P)

Hello and welcome to the next episode of 3P: Pills, Pearls and Patients. Today we're going to kind of be doing a part 2 episode related to governmental policies.

...

 

1

1 applause

Dr. Marina Malak is a family physician in Mississauga, Ontario and a lecturer and faculty member at the University of Toronto. She is actively involved in medical advocacy, and is a board member of the Mississauga Primary Care Network. She is also a member of the National Committee of Continuing Professional Development at the College of Family Physicians of Ontario, and a member of the Research Ethics Board at Trillium Health Partners.

She is passionate about patient care; medical education; and promoting mental, physical, and emotional wellness. She enjoys reading, writing, public speaking, puzzles, doodling in her bullet journal, and creating drawings on Procreate.

Keratosis Pilaris

Teaser: 

Bianca Te, BSc,1Joseph M. Lam, MD, FRCPC,2

1Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.2 Department of Pediatrics, Department of Dermatology and Skin Sciences, University of British Columbia, Vancouver, British Columbia, Canada.

CLINICAL TOOLS

Abstract: Keratosis pilaris (KP) is a common, benign skin condition that primarily affects children and adolescents. It is characterized by small follicular papules resembling “chicken skin” or goosebumps, most often on extensor surfaces of the proximal upper and lower extremities. The exact cause of KP is unclear, however it is believed to follow an autosomal dominant inheritance pattern and may be associated with a mutation in filaggrin, a protein involved in maintaining the skin barrier. This ultimately results in excessive keratin production and deposition surrounding hair follicles. Diagnosis is typically based on the patient’s history and clinical presentation. KP is most often asymptomatic and tends to improve with age. However, treatment is aimed at enhancing cosmetic appearance or relieving mild pruritus. Management includes optimizing skin moisturization and using topical keratolytic agents, though other options such as topical retinoids and laser therapy may also be effective.
Key Words: Keratosis pilaris, keratolytic agents, asymptomatic, benign.

Members of the College of Family Physicians of Canada may claim MAINPRO-M2 Credits for this unaccredited educational program.

www.cfpc.ca/Mainpro_M2

You can take quizzes without subscribing; however, your results will not be stored. Subscribers will have access to their quiz results for future reference.

Pre-test CME Quiz Post-test CME Quiz
Keratosis pilaris presents as numerous small follicular papules resembling “chicken skin” or goosebumps, most often on extensor surfaces of the proximal upper and lower extremities.
Keratosis pilaris is a benign skin condition that often improves with age.
Management of keratosis pilaris is aimed at reducing symptoms such as pruritus and improving cosmetic appearance. Keratolytic agents such as lactic acid or salicylic acid creams are most commonly used for treatment.
Keratosis pilaris is the result of excess keratin production that deposits around the hair follicle, however the exact pathogenesis is not fully understood.
Diagnosis of keratosis pilaris is made on history and physical exam. Dermoscopy and biopsy are not often required, but can be used if other conditions are suspected.
Patients should understand that keratosis pilaris is benign and that there is no cure. It is important to provide reassurance that the condition often improves with age, however some topical treatments may be able to help improve cosmetic appearance.
To have access to full article that these tools were developed for, please subscribe. The cost to subscribe is $80 USD per year and you will gain full access to all the premium content on www.healthplexus.net, an educational portal, that hosts 1000s of clinical reviews, case studies, educational visual aids and more as well as within the mobile app.
Related Terms: Dermatology, Keratosis pilaris, keratolytic agents, asymptomatic, benign
Disclaimer: 
Disclaimer at the end of each page